The Role of Cytoskeleton Protein 4.1 in Immunotherapy

Cytoskeleton protein 4.1 is an essential class of skeletal membrane protein, initially found in red blood cells, and can be classified into four types: 4.1R (red blood cell type), 4.1N (neuronal type), 4.1G (general type), and 4.1B (brain type). As research progressed, it was discovered that cytoske...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-02, Vol.24 (4), p.3777
Main Authors: Si, Chaohua, Yuan, Lihua, Chen, Chen, Wang, Ting, Kang, Qiaozhen
Format: Article
Language:English
Subjects:
Antigens
B cells
Cancer
Care and treatment
Cell cycle
Colorectal cancer
Cytoskeleton
cytoskeleton protein 4.1
Dendritic cells
Development and progression
Diagnosis
Erythrocytes
Immune system
Immunoregulation
Immunotherapy
Influence
Lymphocytes
Medical diagnosis
Membrane proteins
Metastasis
Motility
Oncology, Experimental
Protein 4.1
Proteins
Radiation therapy
Review
Signal transduction
Tumor microenvironment
tumor suppressor
Tumor suppressor genes
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293
cites cdi_FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293
container_end_page
container_issue 4
container_start_page 3777
container_title International journal of molecular sciences
container_volume 24
creator Si, Chaohua
Yuan, Lihua
Chen, Chen
Wang, Ting
Kang, Qiaozhen
description Cytoskeleton protein 4.1 is an essential class of skeletal membrane protein, initially found in red blood cells, and can be classified into four types: 4.1R (red blood cell type), 4.1N (neuronal type), 4.1G (general type), and 4.1B (brain type). As research progressed, it was discovered that cytoskeleton protein 4.1 plays a vital role in cancer as a tumor suppressor. Many studies have also demonstrated that cytoskeleton protein 4.1 acts as a diagnostic and prognostic biomarker for tumors. Moreover, with the rise of immunotherapy, the tumor microenvironment as a treatment target in cancer has attracted great interest. Increasing evidence has shown the immunoregulatory potential of cytoskeleton protein 4.1 in the tumor microenvironment and treatment. In this review, we discuss the role of cytoskeleton protein 4.1 within the tumor microenvironment in immunoregulation and cancer development, with the intention of providing a new approach and new ideas for future cancer diagnosis and treatment.
doi_str_mv 10.3390/ijms24043777
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a4bc81993084a4aa4b724a9b81ac4d0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751924785</galeid><doaj_id>oai_doaj_org_article_4a4bc81993084a4aa4b724a9b81ac4d0</doaj_id><sourcerecordid>A751924785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293</originalsourceid><addsrcrecordid>eNptkstvEzEQhy1ERUvhxhmtxIUDCX4_LkhVxCNSpVaonC2v7U0cdu1g71bKf49DSpsg5MOMx9_8PDMaAN4gOCdEwY9hMxRMISVCiGfgAlGMZxBy8fzIPwcvS9lAiAlm6gU4J1wShqS6AOxu7ZvvqfdN6prFbkzlp-_9mGJzm9PoQ2zoHDXVLIdhimlc-2y2u1fgrDN98a8f7CX48eXz3eLb7Prm63JxdT2zjLJx1hnlFO-4ZdwoyAyn0nDXEomRhJw4qWgLKaoVYmEIssLRTtrWMwwhdFiRS7A86LpkNnqbw2DyTicT9J9Ayitt8hhs7zU1tLUSKUWgrL6pV4GpUa1ExlIHq9ang9Z2agfvrI9jNv2J6OlLDGu9SvdaKY4URVXg_YNATr8mX0Y9hGJ935vo01Q0FnLfCUX7ut_9g27SlGMdVaWEYhQSTJ-olakNhNil-q_di-orwZDCVEhWqfl_qHqcH4JN0Xehxk8SPhwSbE6lZN899oig3q-MPl6Zir89nssj_HdHyG8vKLhy</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779540324</pqid></control><display><type>article</type><title>The Role of Cytoskeleton Protein 4.1 in Immunotherapy</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Si, Chaohua ; Yuan, Lihua ; Chen, Chen ; Wang, Ting ; Kang, Qiaozhen</creator><creatorcontrib>Si, Chaohua ; Yuan, Lihua ; Chen, Chen ; Wang, Ting ; Kang, Qiaozhen</creatorcontrib><description>Cytoskeleton protein 4.1 is an essential class of skeletal membrane protein, initially found in red blood cells, and can be classified into four types: 4.1R (red blood cell type), 4.1N (neuronal type), 4.1G (general type), and 4.1B (brain type). As research progressed, it was discovered that cytoskeleton protein 4.1 plays a vital role in cancer as a tumor suppressor. Many studies have also demonstrated that cytoskeleton protein 4.1 acts as a diagnostic and prognostic biomarker for tumors. Moreover, with the rise of immunotherapy, the tumor microenvironment as a treatment target in cancer has attracted great interest. Increasing evidence has shown the immunoregulatory potential of cytoskeleton protein 4.1 in the tumor microenvironment and treatment. In this review, we discuss the role of cytoskeleton protein 4.1 within the tumor microenvironment in immunoregulation and cancer development, with the intention of providing a new approach and new ideas for future cancer diagnosis and treatment.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms24043777</identifier><identifier>PMID: 36835189</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antigens ; B cells ; Cancer ; Care and treatment ; Cell cycle ; Colorectal cancer ; Cytoskeleton ; cytoskeleton protein 4.1 ; Dendritic cells ; Development and progression ; Diagnosis ; Erythrocytes ; Immune system ; Immunoregulation ; Immunotherapy ; Influence ; Lymphocytes ; Medical diagnosis ; Membrane proteins ; Metastasis ; Motility ; Oncology, Experimental ; Protein 4.1 ; Proteins ; Radiation therapy ; Review ; Signal transduction ; Tumor microenvironment ; tumor suppressor ; Tumor suppressor genes ; Tumors</subject><ispartof>International journal of molecular sciences, 2023-02, Vol.24 (4), p.3777</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293</citedby><cites>FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2779540324/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2779540324?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36835189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Si, Chaohua</creatorcontrib><creatorcontrib>Yuan, Lihua</creatorcontrib><creatorcontrib>Chen, Chen</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Kang, Qiaozhen</creatorcontrib><title>The Role of Cytoskeleton Protein 4.1 in Immunotherapy</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Cytoskeleton protein 4.1 is an essential class of skeletal membrane protein, initially found in red blood cells, and can be classified into four types: 4.1R (red blood cell type), 4.1N (neuronal type), 4.1G (general type), and 4.1B (brain type). As research progressed, it was discovered that cytoskeleton protein 4.1 plays a vital role in cancer as a tumor suppressor. Many studies have also demonstrated that cytoskeleton protein 4.1 acts as a diagnostic and prognostic biomarker for tumors. Moreover, with the rise of immunotherapy, the tumor microenvironment as a treatment target in cancer has attracted great interest. Increasing evidence has shown the immunoregulatory potential of cytoskeleton protein 4.1 in the tumor microenvironment and treatment. In this review, we discuss the role of cytoskeleton protein 4.1 within the tumor microenvironment in immunoregulation and cancer development, with the intention of providing a new approach and new ideas for future cancer diagnosis and treatment.</description><subject>Antigens</subject><subject>B cells</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Cell cycle</subject><subject>Colorectal cancer</subject><subject>Cytoskeleton</subject><subject>cytoskeleton protein 4.1</subject><subject>Dendritic cells</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Erythrocytes</subject><subject>Immune system</subject><subject>Immunoregulation</subject><subject>Immunotherapy</subject><subject>Influence</subject><subject>Lymphocytes</subject><subject>Medical diagnosis</subject><subject>Membrane proteins</subject><subject>Metastasis</subject><subject>Motility</subject><subject>Oncology, Experimental</subject><subject>Protein 4.1</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Signal transduction</subject><subject>Tumor microenvironment</subject><subject>tumor suppressor</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkstvEzEQhy1ERUvhxhmtxIUDCX4_LkhVxCNSpVaonC2v7U0cdu1g71bKf49DSpsg5MOMx9_8PDMaAN4gOCdEwY9hMxRMISVCiGfgAlGMZxBy8fzIPwcvS9lAiAlm6gU4J1wShqS6AOxu7ZvvqfdN6prFbkzlp-_9mGJzm9PoQ2zoHDXVLIdhimlc-2y2u1fgrDN98a8f7CX48eXz3eLb7Prm63JxdT2zjLJx1hnlFO-4ZdwoyAyn0nDXEomRhJw4qWgLKaoVYmEIssLRTtrWMwwhdFiRS7A86LpkNnqbw2DyTicT9J9Ayitt8hhs7zU1tLUSKUWgrL6pV4GpUa1ExlIHq9ang9Z2agfvrI9jNv2J6OlLDGu9SvdaKY4URVXg_YNATr8mX0Y9hGJ935vo01Q0FnLfCUX7ut_9g27SlGMdVaWEYhQSTJ-olakNhNil-q_di-orwZDCVEhWqfl_qHqcH4JN0Xehxk8SPhwSbE6lZN899oig3q-MPl6Zir89nssj_HdHyG8vKLhy</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Si, Chaohua</creator><creator>Yuan, Lihua</creator><creator>Chen, Chen</creator><creator>Wang, Ting</creator><creator>Kang, Qiaozhen</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230201</creationdate><title>The Role of Cytoskeleton Protein 4.1 in Immunotherapy</title><author>Si, Chaohua ; Yuan, Lihua ; Chen, Chen ; Wang, Ting ; Kang, Qiaozhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antigens</topic><topic>B cells</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Cell cycle</topic><topic>Colorectal cancer</topic><topic>Cytoskeleton</topic><topic>cytoskeleton protein 4.1</topic><topic>Dendritic cells</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Erythrocytes</topic><topic>Immune system</topic><topic>Immunoregulation</topic><topic>Immunotherapy</topic><topic>Influence</topic><topic>Lymphocytes</topic><topic>Medical diagnosis</topic><topic>Membrane proteins</topic><topic>Metastasis</topic><topic>Motility</topic><topic>Oncology, Experimental</topic><topic>Protein 4.1</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Signal transduction</topic><topic>Tumor microenvironment</topic><topic>tumor suppressor</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Si, Chaohua</creatorcontrib><creatorcontrib>Yuan, Lihua</creatorcontrib><creatorcontrib>Chen, Chen</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Kang, Qiaozhen</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Si, Chaohua</au><au>Yuan, Lihua</au><au>Chen, Chen</au><au>Wang, Ting</au><au>Kang, Qiaozhen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Cytoskeleton Protein 4.1 in Immunotherapy</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>24</volume><issue>4</issue><spage>3777</spage><pages>3777-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Cytoskeleton protein 4.1 is an essential class of skeletal membrane protein, initially found in red blood cells, and can be classified into four types: 4.1R (red blood cell type), 4.1N (neuronal type), 4.1G (general type), and 4.1B (brain type). As research progressed, it was discovered that cytoskeleton protein 4.1 plays a vital role in cancer as a tumor suppressor. Many studies have also demonstrated that cytoskeleton protein 4.1 acts as a diagnostic and prognostic biomarker for tumors. Moreover, with the rise of immunotherapy, the tumor microenvironment as a treatment target in cancer has attracted great interest. Increasing evidence has shown the immunoregulatory potential of cytoskeleton protein 4.1 in the tumor microenvironment and treatment. In this review, we discuss the role of cytoskeleton protein 4.1 within the tumor microenvironment in immunoregulation and cancer development, with the intention of providing a new approach and new ideas for future cancer diagnosis and treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36835189</pmid><doi>10.3390/ijms24043777</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2023-02, Vol.24 (4), p.3777
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4a4bc81993084a4aa4b724a9b81ac4d0
source Publicly Available Content Database; PubMed Central
subjects Antigens
B cells
Cancer
Care and treatment
Cell cycle
Colorectal cancer
Cytoskeleton
cytoskeleton protein 4.1
Dendritic cells
Development and progression
Diagnosis
Erythrocytes
Immune system
Immunoregulation
Immunotherapy
Influence
Lymphocytes
Medical diagnosis
Membrane proteins
Metastasis
Motility
Oncology, Experimental
Protein 4.1
Proteins
Radiation therapy
Review
Signal transduction
Tumor microenvironment
tumor suppressor
Tumor suppressor genes
Tumors
title The Role of Cytoskeleton Protein 4.1 in Immunotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A09%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Cytoskeleton%20Protein%204.1%20in%20Immunotherapy&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Si,%20Chaohua&rft.date=2023-02-01&rft.volume=24&rft.issue=4&rft.spage=3777&rft.pages=3777-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms24043777&rft_dat=%3Cgale_doaj_%3EA751924785%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-fa9d96f6c56a905a648a6db38218063d894b04100627a31c7d4f8cbe52000d293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2779540324&rft_id=info:pmid/36835189&rft_galeid=A751924785&rfr_iscdi=true